eDrugsRenalHDB

Author:	Fred C. Hirning, Pharm.D, FAPhA [Send Author Email]
Homepage:	http://www.geocities.com/fhirning/eDrugsSoftware.html
Date Added:	February 18, 2003
Description:	eDrugsRenalHDB is an add-on for HanDBase that contains a listing of 560 medications and recommended dosage adjustments for patients with renal insufficiency. Each listing displays generic name, trade name, class, and dosage recommendations for GFR 50-90, GFR 10-50, and GFR <10. Multiple recommendations are listed when applicable. Contact the developer at fhirning@uop.edu
Has Data:	Yes
Has Forms:	No
Price:	FREE
Version:	HanDBase v.2.7x or greater
File:	edrugsrenalhdb.zip          Downloads: This Month 44 / Total* 3815
Note:	MAC Users will need to enter the filename edrugsrenalhdb.zip when saving this file.

Other Titles from Fred C. Hirning, Pharm.D, FAPhA

12/20/2001 eDrugsDataHDB [Medical]
eDrugsDataHDB is an add on applet for HanDBase containing over 10,000 drug names and dosage forms. It contains over 2,300 generic listings plus brand names and dosage forms. Each drug listing gives the generic name, brand name, usual dose, use or class and pregnancy risk factor plus most have additional information and notes relating to the drug's usage. The usual dosages have recently been added. Many new investigational and orphan drugs have also been added to the database. The list is extensive and very much up to date. It includes drugs that are still investigational but likely to be FDA approved in the near future. As this occurs the database is updated. Contact the developer at fhirning@uop.edu

02/18/2003 eDrugsDataHDB [Automobiles]
eDrugsDataHDB is an add on database for HanDBase containing over 13,000 drug names and dosage forms. It contains over 2,600 generic listings plus brand names and dosage forms. Each drug listing gives the generic name, brand name, usual dose, use or class and pregnancy risk plus most have additional information and notes relating to the drug's usage. The usual dosages have recently been added. Many new investigational and orphan drugs have also been added to the database.The list is extensive and very much up to date. It includes drugs that are still investigational but likely to be FDA approved in the near future. As this occurs the database is updated. Contact the developer at fhirning@uop.edu..